Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Gires

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The EMBO Journal|November 14, 1997
Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor moleculeO Gires, U Zimber-Strobl, R Gonnella, et al.
British Journal of Cancer|July 4, 2014
EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205P Massoner, T Thomm, B Mack, et al.
International Journal of Immunopathology and Pharmacology|July 13, 2006
COX-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectorsS Lang, A Picu, T Hofmann, et al.
Journal of Virology|September 12, 1998
Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylationM Baumann, H Mischak, S Dammeier, et al.
The EMBO Journal|June 5, 1999
Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteinsO Gires, F Kohlhuber, E Kilger, et al.
Cellular and Molecular Life Sciences : CMLS|May 14, 2004
Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technologyO Gires, M Münz, M Schaffrik, et al.
Oncogene|October 22, 2013
Context-dependent adaption of EpCAM expression in early systemic esophageal cancerC Driemel, H Kremling, S Schumacher, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The EMBO Journal|November 14, 1997
Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor moleculeO Gires, U Zimber-Strobl, R Gonnella, et al.
British Journal of Cancer|July 4, 2014
EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205P Massoner, T Thomm, B Mack, et al.
International Journal of Immunopathology and Pharmacology|July 13, 2006
COX-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectorsS Lang, A Picu, T Hofmann, et al.
Journal of Virology|September 12, 1998
Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylationM Baumann, H Mischak, S Dammeier, et al.
The EMBO Journal|June 5, 1999
Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteinsO Gires, F Kohlhuber, E Kilger, et al.
Cellular and Molecular Life Sciences : CMLS|May 14, 2004
Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technologyO Gires, M Münz, M Schaffrik, et al.
Oncogene|October 22, 2013
Context-dependent adaption of EpCAM expression in early systemic esophageal cancerC Driemel, H Kremling, S Schumacher, et al.
Pageof 2